Follow the people · Insider
Aik Na Tan
Aik Na Tan files insider transactions with the SEC as a director of Wave Life Sciences (WVE). We hold 1 disclosed purchase or sale filed since 20 August 2020, 1 of them in the last 90 days.
- Files forWVE
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure13 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 August 2020 — 11 August 2026Director · Wave Life Sciences (WVE)29 Form 4 lines · source: SEC Form 4
Everything they disclosed
29 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 432 shares of Wave Life SciencesSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- exercised options over 32,230 shares of Wave Life Sciences (a derivative holding)SEC Form 410 December 2025Share Option (right to buy) · traded 8 December 2025 · filed 10 December 2025
- exercised options over 45,000 shares of Wave Life Sciences (a derivative holding)SEC Form 410 December 2025Share Option (right to buy) · traded 8 December 2025 · filed 10 December 2025
- exercised options over 21,000 shares of Wave Life Sciences (a derivative holding)SEC Form 410 December 2025Share Option (right to buy) · traded 8 December 2025 · filed 10 December 2025
- exercised options over 21,000 shares of Wave Life Sciences (a derivative holding)SEC Form 410 December 2025Share Option (right to buy) · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 7,494 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 7,494 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- exercised options over 32,230 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 15,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 17,230 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- exercised options over 45,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 20,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 25,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- exercised options over 21,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 21,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- exercised options over 21,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 21,000 shares of Wave Life SciencesSEC Form 410 December 2025Ordinary Shares · traded 8 December 2025 · filed 10 December 2025
- exercised options over 21,000 shares of Wave Life Sciences (a derivative holding)SEC Form 419 August 2025Share Option (right to buy) · traded 15 August 2025 · filed 19 August 2025
- exercised options over 21,000 shares of Wave Life SciencesSEC Form 419 August 2025Ordinary Shares · traded 15 August 2025 · filed 19 August 2025
- ▼ sold on the open market 21,000 shares of Wave Life SciencesSEC Form 419 August 2025Ordinary Shares · traded 15 August 2025 · filed 19 August 2025
- was granted 152,400 shares of Wave Life Sciences (a derivative holding)SEC Form 413 August 2025Share Option (right to buy) · traded 11 August 2025 · filed 13 August 2025
- was granted 25,400 shares of Wave Life SciencesSEC Form 413 August 2025Ordinary Shares · traded 11 August 2025 · filed 13 August 2025
- ▼ sold on the open market 1,127 shares of Wave Life SciencesSEC Form 47 August 2025Ordinary Shares · traded 5 August 2025 · filed 7 August 2025
- was granted 32,230 shares of Wave Life Sciences (a derivative holding)SEC Form 414 August 2024Share Option (right to buy) · traded 12 August 2024 · filed 14 August 2024
- was granted 16,115 shares of Wave Life SciencesSEC Form 414 August 2024Ordinary Shares · traded 12 August 2024 · filed 14 August 2024
- was granted 45,000 shares of Wave Life Sciences (a derivative holding)SEC Form 49 August 2023Share Option (right to buy) · traded 7 August 2023 · filed 9 August 2023
- was granted 21,000 shares of Wave Life Sciences (a derivative holding)SEC Form 417 August 2022Share Option (right to buy) · traded 15 August 2022 · filed 17 August 2022
- was granted 21,000 shares of Wave Life Sciences (a derivative holding)SEC Form 418 August 2021Share Option (right to buy) · traded 16 August 2021 · filed 18 August 2021
- was granted 21,000 shares of Wave Life Sciences (a derivative holding)SEC Form 420 August 2020Share Option (right to buy) · traded 18 August 2020 · filed 20 August 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.